Endo Pharmaceuticals Overview

  • Founded
  • 1997
Founded
  • Status
  • Public
  • Employees
  • 3,172
Employees
  • Stock Symbol
  • ENDP
Stock Symbol
  • Investments
  • 21
  • Share Price
  • $5.64
  • (As of Monday Closing)

Endo Pharmaceuticals General Information

Description

After a string of acquisitions and divestitures, Endo is a specialty pharmaceutical company with a considerable presence in pain management. The acquisitions of Auxilium and Par increased the company's presence in urology and generics, respectively.

Contact Information

Website
Formerly Known As
Endo Laboratories
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • First Floor, Minerva House
  • Simmonscourt Road, Ballsbridge
  • Dublin
  • Ireland
+353 (01) 000 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Endo Pharmaceuticals Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$5.64 $4.98 $2.08 - $7.10 $1.3B 230M 4.77M -$0.70

Endo Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 7,701,989 7,997,931 8,781,594 9,273,096
Revenue 3,002,219 2,914,364 2,947,078 3,468,858
EBITDA 887,453 806,692 306,531 (11,011)
Net Income (157,570) (422,636) (1,031,469) (2,035,433)
Total Assets 9,165,134 9,389,527 10,132,393 11,635,580
Total Debt 8,390,797 8,453,111 8,258,419 8,276,237
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Endo Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Endo Pharmaceuticals‘s full profile, request access.

Request a free trial

Endo Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
After a string of acquisitions and divestitures, Endo is a specialty pharmaceutical company with a considerable presence
Pharmaceuticals
Dublin, Ireland
3,172 As of 2019
000.00
000000&0

0000 000

t enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo cons
000000000000000
Petach Tikva, Israel
00000 As of 0000
00000
00000000000 00000

00000

elit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, su
000000000000000
Hatfield, United Kingdom
00000 As of 0000
00.00
00.00 0000-00-00
000000&0 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Endo Pharmaceuticals Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Teva Pharmaceutical Industries Corporate Backed or Acquired Petach Tikva, Israel 00000 00000 00000000000 00000
00000 Corporation Hatfield, United Kingdom 00000 00.00 000000&0 00.00
000000000 000000 Corporation Hyderabad, India 00000 00000 000000000 00000
000 Corporation Parkville, Australia 00000 0000
000000 00000 Corporation Mumbai, India 0000
You’re viewing 5 of 7 competitors. Get the full list »

Endo Pharmaceuticals Executive Team (28)

Name Title Board Seat Contact Info
Blaise Coleman Chief Executive Officer & Board Member
Patrick Barry Executive Vice President & President
Mark Bradley Chief Financial Officer, Finance & Executive Vice President
Terrance Coughlin Chief Operating Officer, Operations & Executive Vice President
Susan Williamson Senior Vice President & Chief Compliance Officer
You’re viewing 5 of 28 executive team members. Get the full list »

Endo Pharmaceuticals Board Members (14)

Name Representing Role Since
000000 0000000 Endo Pharmaceuticals Board Member 000 0000
000000 0000000 Endo Pharmaceuticals Chief Executive Officer & Board Member 000 0000
00000000 00000 Endo Pharmaceuticals Board Member 000 0000
0000 00000000 Self Board Member 000 0000
0000000 00000 Endo Pharmaceuticals Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

Endo Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Endo Pharmaceuticals Investments & Acquisitions (21)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000000 00000 19-Oct-2020 000000000000000000 00000 Pharmaceuticals 000000 0000000
00000000 000000000 26-Apr-2018 000000000000000000 00000 Pharmaceuticals 0000 0000000000
00000 00000000 (00 01-Oct-2015 000000000000000000 00000 Medical Supplies
000 00000000000000 25-Sep-2015 000000000000000000 00.00 Pharmaceuticals
Auxilium Pharmaceuticals 29-Jan-2015 Merger/Acquisition 00.000 Pharmaceuticals
You’re viewing 5 of 21 investments and acquisitions. Get the full list »

Endo Pharmaceuticals Subsidiaries (4)

Company Name Industry Location Founded
Somerset Therapeutics Pharmaceuticals Somerset, NJ 2015
00000000 000000000 Pharmaceuticals Chesterbrook, PA 0000
0000000 0000 Pharmaceuticals Saint-Laurent, Canada 0000
000 00000000000000 Pharmaceuticals Ramapo, NY 0000
To view Endo Pharmaceuticals’s complete subsidiaries history, request access »

Endo Pharmaceuticals Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 000000000000 24-Jul-2014 000000000000000000 Completed
  • 0000 0000000000000
0000000000000 15-Jul-2010 000000000000000000 00000 Completed
  • 0000 0000000000000
Endo Pharmaceuticals Solutions 05-Jan-2009 Merger/Acquisition 00000 Completed
To view Endo Pharmaceuticals’s complete exits history, request access »